Alcohol Use Disorder
Alcohol Use Disorder (AUD), commonly known as alcoholism, is characterized by uncontrolled drinking and a preoccupation with alcohol, continuing despite significant negative consequences and evidence of dependence and withdrawal symptoms. According to the World Health Organization, as of 2016, around 283 million people globally were affected by this condition.
Health Outcomes
- Alleviated Alcohol-Induced Gastric Ulcers
- Altered Neurobiological Markers
- Altered Pyridoxine Concentration
- Attenuation of Health Effects After Cessation
- Changed Magnesium Level
- Enhanced Detoxification
- Enhanced Reward Responsiveness
- Impaired Spermatogenesis
- Improved Alcohol Metabolism
- Improved Alcohol-Related Neuropsychiatric Symptoms
- Improved Alcohol-induced Liver Injury
- Improved Ataxia Rating Scale Score
- Improved Cerebellar Ataxia
- Improved Consumer Acceptance
- Improved Detoxification
- Improved Enzyme Levels (ADH, ALDH)
- Improved General Health
- Improved Immune Function Post-Cessation
- Improved Inhibitory Control
- Improved Liver Antioxidant Capacity
- Improved Liver Function (γ-glutamyltranspeptidase)
- Improved Psychosocial Domain Score
- Improved Safe Consumption Practices
- Improved Seizure Control
- Improved Serum Albumin Levels
- Increased ALDH Levels
- Increased Alcohol Dehydrogenase Levels in Liver
- Increased Anion Gap
- Increased Continuous Abstinence Rate
- Increased Days Abstinent
- Increased Dopamine Transporter Binding
- Increased High-Density Lipoprotein Levels
- Increased Jejunal Permeability
- Increased Liver Alcohol Metabolizing Enzyme Activity
- Increased Mean Corpuscular Hemoglobin
- Increased Nausea
- Increased Negative Transcriptional Regulation
- Increased Production of Acetate
- Increased Red Blood Cell Folate Concentration
- Increased Reticulocyte Hemoglobin Content
- Increased Risk of Esophageal Cancer
- Increased Risk of Laryngeal Cancer
- Increased Risk of Oral Cavity Cancer
- Increased Safety
- Increased Thiamine Diphosphate Level
- Increased β-glucosidase Levels
- Lapse in Effect Post-Cessation
- No CYP1A2 or CYP3A4 Interaction
- No Change in Objective Stress Markers
- No Long-Term Impact on Gut Microbiota
- No Significant Change in Health Variables
- No Significant Difference Compared to Placebo
- Prevented Exacerbation of Thiamine Deficiency
- Prevented Production of Harmful Substances
- Prevented Relapse
- Prevention of Alcoholic Liver Disease
- Reduced Acute Liver Injury
- Reduced Acute Pancreatitis Severity
- Reduced Alcohol Consumption
- Reduced Alcohol Craving
- Reduced Alcohol-Induced Liver Inflammation
- Reduced Alcohol-Induced Liver Lipid Accumulation
- Reduced Alcohol-Induced Liver Oxidative Stress
- Reduced Alcohol-Related Gut Microbiome Dysbiosis
- Reduced Automaticity of Drinking
- Reduced Cancer Mortality
- Reduced Combined Drug Use
- Reduced Composite Score
- Reduced Compulsive Symptoms
- Reduced Cost-Effectiveness in Reducing AAD
- Reduced Craving
- Reduced Craving Rating
- Reduced Dependence Severity
- Reduced Drinking Obsessions
- Reduced Heavy Drinking Day
- Reduced Incidence of Liver Cancer
- Reduced Interference Due to Drinking
- Reduced Intraoperative Anesthetic Requirement
- Reduced Magnesium Level
- Reduced NREM Sleep Quality
- Reduced Oral Leukoplakia Progression
- Reduced P3b Amplitude
- Reduced Phosphorus Level
- Reduced Red Blood Cell Folate
- Reduced Red Blood Cell Folate Concentration
- Reduced Relapse
- Reduced Relapse Rate
- Reduced Serum Phosphate Level
- Reduced Sperm Motility
- Reduced Suicide Attempt
- Reduced Suicide Ideation
- Reduced Suicide-Related Emergency or Hospital Visit
- Reduced Suicide-Related Endpoints
- Reduced Thiamin Pyrophosphate Effect
- Reduced Total Testosterone Level
- Reduced Treatment Discontinuation
- Reduced Treatment Interruption
- Reduced Undesirable Compounds
- Reduced Visual Reaction Time
- Reduced Vitamin B6 Level
- Reduced Wernicke Encephalopathy Symptoms
- Reduced Withdrawal Symptom
- Resolved Keratomalacia
- Safety for Consumption
- Safety of Consumption
- Sustained Effects with Ongoing Consumption